Celldex Therapeutics Inc (CLDX)

Working Capital Ratio

84.82%

Quarterly · Period ending:

CLDX logo

CLDX Working Capital Ratio

Latest reported84.82%
CLDX Quarterly Working Capital Ratio (71.88% → 84.82%)
High-resolution chart · PNG

CLDX working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
69.8041%
73.706%
73.012%
86.2972%
69.557%
70.8027%
61.8085%
66.6667%
46.6667%
49.2386%
54.185%
53.7849%
48.9796%
59.4828%
46.9388%
58.2609%
71.6418%
74.6667%
68.0233%
72.5389%
51.2821%
51.5528%
60.5405%
50.4274%
66.443%
70.5556%
72.9469%
68.3794%
72.3022%
76.5472%
78.852%
62.2093%
68.75%
71.4286%
74.5902%
75.6757%
77.037%
80.3571%
80.9859%
81.5436%
59.0909%
62.2047%
64.4444%
61.1842%
65.3846%
61.8644%
62.1212%
79.2308%
84.2466%
71.875%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.